PerkinElmer To Buy UK-Based Immunodiagnostics For $155M

PerkinElmer will add chemiluminescence products in endocrinology, autoimmunity and diagnostics to its portfolio with the planned buyout of Immunodiagnostics.

M&A

PerkinElmer, Inc. is the latest company to bolster its in-vitro diagnostics business with a buyout.

The company announced on 17 May it acquired UK-based Immunodiagnostics Systems Holdings PCL for about $155m in cash. PerkinElmer said the transaction has a total enterprise value of about $124m...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business